Open access
Sep 2026
Bufalin Targets CENPA-modulated Glycolysis via PI3K/AKT in Hepatocellular Carcinoma: A Bioinformatics, In Vitro and Preliminary In Vivo Evidence.
Findings suggest that bufalin may suppress CENPA-associated glycolysis and HCC cell migration through modulation of PI3K/AKT signaling.
Muhammad Muddasar Saeed, Tian-Fu Wei, Muhammad K. Iqbal et al.
· Molecular and Cellular Endoc... · 0 citations